Avalon Investment & Advisory’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $15.9M | Sell |
102,286
-2,224
| -2% | -$359K | 0.43% | 71 |
|
|
2022
Q4 | $18.5M | Sell |
104,510
-7,438
| -7% | -$1.28M | 0.53% | 64 |
|
|
2022
Q3 | $18.3M | Sell |
111,948
-1,773
| -2% | -$300K | 0.57% | 56 |
|
|
2022
Q2 | $20.2M | Sell |
113,721
-358
| -0.3% | -$63.8K | 0.57% | 56 |
|
|
2022
Q1 | $20.2M | Buy |
114,079
+5,416
| +5% | +$922K | 0.49% | 70 |
|
|
2021
Q4 | $18.6M | Sell |
108,663
-11,032
| -9% | -$1.81M | 0.46% | 69 |
|
|
2021
Q3 | $19.3M | Sell |
119,695
-6,225
| -5% | -$1.06M | 0.45% | 68 |
|
|
2021
Q2 | $20.7M | Sell |
125,920
-7,151
| -5% | -$1.18M | 0.46% | 68 |
|
|
2021
Q1 | $21.9M | Sell |
133,071
-14,290
| -10% | -$2.31M | 0.5% | 70 |
|
|
2020
Q4 | $23.2M | Buy |
147,361
+167
| +0.1% | +$24.6K | 0.47% | 64 |
|
|
2020
Q3 | $21.9M | Buy |
147,194
+683
| +0.5% | +$101K | 0.49% | 61 |
|
|
2020
Q2 | $20.6M | Sell |
146,511
-5,533
| -4% | -$806K | 0.48% | 60 |
|
|
2020
Q1 | $19.9M | Sell |
152,044
-78,467
| -34% | -$11.1M | 0.51% | 56 |
|
|
2019
Q4 | $33.6M | Sell |
230,511
-5,762
| -2% | -$782K | 0.69% | 42 |
|
|
2019
Q3 | $30.6M | Sell |
236,273
-10,762
| -4% | -$1.42M | 0.67% | 41 |
|
|
2019
Q2 | $34.4M | Sell |
247,035
-7,083
| -3% | -$980K | 0.76% | 34 |
|
|
2019
Q1 | $35.5M | Sell |
254,118
-71,462
| -22% | -$9.57M | 0.81% | 30 |
|
|
2018
Q4 | $42M | Buy |
325,580
+141,529
| +77% | +$19.7M | 1.08% | 20 |
|
|
2018
Q3 | $25.4M | Buy |
184,051
+826
| +0.5% | +$110K | 0.71% | 38 |
|
|
2018
Q2 | $22.2M | Sell |
183,225
-101,456
| -36% | -$12.7M | 0.66% | 54 |
|
|
2018
Q1 | $36.5M | Buy |
284,681
+3,720
| +1% | +$503K | 1.13% | 18 |
|
|
2017
Q4 | $39.3M | Sell |
280,961
-12,557
| -4% | -$1.75M | 1.23% | 14 |
|
|
2017
Q3 | $38.2M | Buy |
293,518
+883
| +0.3% | +$117K | 1.21% | 17 |
|
|
2017
Q2 | $38.7M | Sell |
292,635
-2,790
| -0.9% | -$356K | 1.29% | 13 |
|
|
2017
Q1 | $36.8M | Buy |
295,425
+312
| +0.1% | +$37.3K | 1.26% | 18 |
|
|
2016
Q4 | $34M | Sell |
295,113
-7,491
| -2% | -$865K | 1.23% | 22 |
|
|
2016
Q3 | $35.7M | Sell |
302,604
-40,060
| -12% | -$4.86M | 1.34% | 17 |
|
|
2016
Q2 | $41.6M | Sell |
342,664
-68,216
| -17% | -$7.75M | 1.61% | 12 |
|
|
2016
Q1 | $44.5M | Buy |
410,880
+101,250
| +33% | +$10.5M | 1.93% | 11 |
|
|
2015
Q4 | $31.8M | Sell |
309,630
-19,107
| -6% | -$1.92M | 1.37% | 17 |
|
|
2015
Q3 | $30.7M | Buy |
328,737
+12,394
| +4% | +$1.2M | 1.35% | 15 |
|
|
2015
Q2 | $30.8M | Buy |
316,343
+1,478
| +0.5% | +$148K | 1.33% | 17 |
|
|
2015
Q1 | $31.7M | Buy |
314,865
+9,166
| +3% | +$932K | 1.38% | 15 |
|
|
2014
Q4 | $32M | Buy |
305,699
+21,062
| +7% | +$2.22M | 1.46% | 15 |
|
|
2014
Q3 | $30.3M | Buy |
284,637
+3,974
| +1% | +$412K | 1.53% | 16 |
|
|
2014
Q2 | $29.4M | Buy |
280,663
+4,005
| +1% | +$405K | 1.48% | 17 |
|
|
2014
Q1 | $27.2M | Sell |
276,658
-4,723
| -2% | -$438K | 1.5% | 17 |
|
|
2013
Q4 | $25.8M | Sell |
281,381
-1,224
| -0.4% | -$113K | 1.44% | 16 |
|
|
2013
Q3 | $24.5M | Sell |
282,605
-17,422
| -6% | -$1.56M | 1.58% | 15 |
|
|
2013
Q2 | $25.8M | Buy |
+300,027
| New | +$25.5M | 1.54% | 14 |
|
Other funds holding JNJ
Avalon Investment & Advisory's JNJ Position: Q1 2023 in Review
Avalon Investment & Advisory reduced its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2023, selling an estimated $359K and leaving 102,286 shares worth $15.9M. The position accounts for 0.43% of the portfolio, ranked #71.
Avalon Investment & Advisory first reported a position in JNJ in Q2 2013 and has held it in 40 quarters since. The position peaked at $44.5M in Q1 2016. 3,728 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.
- Avalon Investment & Advisory held 102,286 shares of Johnson & Johnson worth $15.9M as of Q1 2023.
- Avalon Investment & Advisory sold 2,224 Johnson & Johnson shares in Q1 2023, an estimated $359K.
- Johnson & Johnson made up 0.43% of Avalon Investment & Advisory's portfolio in Q1 2023, its #71 holding.
- Avalon Investment & Advisory first reported a position in Johnson & Johnson in Q2 2013 and has held it in 40 quarters since.
- Avalon Investment & Advisory's Johnson & Johnson position peaked at $44.5M in Q1 2016.
- 3,728 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.
Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.